healthcare Utilization In The Aethera Trial: Phase 3 Study Of Brentuximab Vedotin In Patients At Increased Risk Of Residual Hodgkin Lymphoma Post Asct : 177
Hematological Oncology(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Hematological Oncology(2015)